A solid phospholipid-bile salts-mixed micelles based on the fast dissolving oral films to improve the oral bioavailability of poorly water-soluble drugs
Source abstract
Abstract
The phospholipid-bile salts-mixed micelles (PL-BS-MMs) are potent carriers used for oral absorption of drugs that are poorly soluble in water; however, there are many limitations associated with liquid formulations. In the current study, the feasibility of preparing the fast dissolving oral films (FDOFs) containing PL-BS-MMs was examined. FDOFs incorporated with Cucurbitacin B (Cu B)-loaded PL-sodium deoxycholate (SDC)-MMs have been developed and characterized. To prepare the MMs and to serve as the micellar carrier, a weight ratio of 1:0.8 and total concentration of 54 mg/mL was selected for the PL/SDC based on the size, size distribution, zeta potential, encapsulation efficiency, and morphology. The concentration of Cu B was determined to be 5 mg/mL. Results showed that a narrow size distributed nanomicelles with a mean particle size of 86.21 ± 6.11 nm and a zeta potential of −31.21 ± 1.17 mV was obtained in our optimized Cu B-PL/SDC-MMs formulation. FDOFs were produced by solvent casting method and the formulation with 50 mg/mL of pullulan and 40 mg/mL of PEG 400 were deemed based on the physico-mechanical properties. The FDOFs containing Cu B-PL/SDC-MMs were easily reconstituted in a transparent and clear solution giving back a colloidal system with spherical micelles in the submicron range. In the in vitro dissolution test, the FDOFs containing Cu B-PL/SDC-MMs showed an increased dissolution velocity markedly. The pharmacokinetics study showed that the FDOFs containing PL-SDC-MMs not only kept the absorption properties as same as the PL-SDC-MMs, but also significantly increased the oral bioavailability of Cu B compared to the Cu B suspension (p < 0.05). This study showed that the FDOFs containing Cu B-PL/SDC-MMs could represent a novel platform for the delivery of poorly water-soluble drugs via oral administration. Furthermore, the integration with the FDOFs could also provide a simple and cost-effective manner for the solidification of PL-SDC-MMs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Drug Transport and Resistance Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Agil A, Miró M, Jimenez J et al (1999) Isolation of anti-hepatotoxic principle form the juice of Ecballium elaterium. Planta Med 65:673–67510.1055/s-2006-960847 ↗
2. Bajdik J, Marciello M, Caramella C et al (2009) Evaluation of surface and microstructure of differently plasticized chitosan films. J Pharm Biomed Anal 49:655–65910.1016/j.jpba.2008.12.020 ↗
3. Boateng JS, Stevens HNE, Eccleston GM et al (2009) Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces. Drug Dev Ind Pharm 35:986–99610.1080/03639040902744704 ↗
4. Borsadia S, O`Halloran D, Osborne JL (2003) Quick dissolving films-a novel approach to drug delivery. Drug Deliv Technol 3:63–66
5. Cilurzo F, Cupone IE, Minghetti P et al (2008) Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 70(3):895–90010.1016/j.ejpb.2008.06.032 ↗
6. Dong FX, Xie YC, Qi JP et al (2013) Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating. Int J Nanomed 8:1653–1663
7. Duan RL, Sun X, Liu J et al (2011) Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility. Acta Pharmacol Sin 32(1):108–11510.1038/aps.2010.192 ↗
8. Gaucher G, Dufresne MH, Sant VP et al (2005) Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109(1–3):169–18810.1016/j.jconrel.2005.09.034 ↗
9. Hammad MA, Müller BW (1998) Solubility and stability of tetrazepam in mixed micelles. Eur J Pharm Sci 7(1):49–5510.1016/S0928-0987(98)00006-2 ↗
10. Hu HY, Liu D, Zhao XL et al (2013) Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm 39(5):770–77910.3109/03639045.2012.702348 ↗
11. Jin SX, Fu SS, Han J et al (2012) Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles. J Drug Target 20(7):615–62210.3109/1061186X.2012.702770 ↗
12. Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47(1):113–13110.1016/S0169-409X(00)00124-1 ↗
13. Komatsu H, Kitajima A, Okada S (1995) Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pharm Bull 43:1412–141510.1248/cpb.43.1412 ↗
14. Li CY, Hou SX, Yang K et al (2001) Study on quantitative determination of cucurbitacins B in plasma by HPLC. Chin Pharm J 36:557–563
15. Liu J, Gong T, Wang CG et al (2007) Solid lipid nanoparticles loaded with insulin by sodium cholate–phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 340:153–16210.1016/j.ijpharm.2007.03.009 ↗
16. Londhe VY, Umalkar KB (2012) Formulation development and evaluation of fast dissolving film of telmisartan. Indian J Pharm Sci 74:122–12610.4103/0250-474X.103842 ↗
17. Mishra R, Amin A (2007) Quick API delivery. Pharm Tech Eur 19(10):35–39
18. Molavi O, Ma Z, Mahmud A et al (2008) Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm 347:118–12710.1016/j.ijpharm.2007.06.032 ↗
19. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 50:161–17710.1016/S0939-6411(00)00087-4 ↗
20. Oh H, Mun YJ, Im SJ et al (2002) Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells. Planta Med 68:832–83310.1055/s-2002-34418 ↗
21. Peters RR, Saleh TF, Lora M et al (1999) Anti-inflammatory effects of the products from Wilbrandia ebracteata on carrageenan-induced pleurisy in mice. Life Sci 64:2429–243710.1016/S0024-3205(99)00200-3 ↗
22. Porter CJ, Trevaskis NL, Charman WN (2007) Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231–24810.1038/nrd2197 ↗
23. Savic R, Luo L, Eisenberg A, Maysinger D (2003) Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300(5619):615–61810.1126/science.1078192 ↗
24. Shen BD, Shen CY, Yuan XD et al (2013) Development and characterization of an orodispersible film containing drug nanoparticles. Eur J Pharm Biopharm 85(3):1348–135610.1016/j.ejpb.2013.09.019 ↗
25. Tan YN, Qi JP, Lu Y et al (2013) Lecithin in mixed micelles attenuates the cytotoxicity of bile salts in Caco-2 cells. Toxicol In Vitro 27:714–72010.1016/j.tiv.2012.11.018 ↗
26. Tannin-Spitz T, Grossman S, Dovrat S et al (2007) Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol 73:56–6710.1016/j.bcp.2006.09.012 ↗
27. Teelmann K, Schläppi B, Schüpbach M et al (1984) Preclinical safety evaluation of intravenously administered mixed micelles. Arzneim Forsch 34(11):1517–1523
28. Ukiya M, Akihisa T, Yasukawa K et al (2002) Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica. J Nat Prod 65:179–18310.1021/np010423u ↗
29. Wang W, Zhao X, Hu H et al (2010) Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability. Drug Deliv 17(3):114–12210.3109/10717540903580176 ↗
30. Xiao L, Yi T, Liu Y (2013) A new self-microemulsifying mouth dissolving film to improve the oral bioavailability of poorly water soluble drugs. Drug Dev Ind Pharm 39(9):1284–129010.3109/03639045.2012.723716 ↗
31. Yesilada E, Tanaka S, Sezik E et al (1988) Isolation of an anti-inflammatory principle from the fruit juice of Ecballium elaterium. J Nat Prod 51:504–50810.1021/np50057a008 ↗